Literature DB >> 10925780

Rat inbred PD/cub strain as a model of dyslipidemia and insulin resistance.

L Sedová1, L Kazdová, O Seda, D Krenová, V Kren.   

Abstract

Genome scan and metabolic profile of the PD/Cub rat inbred strain in comparison with SHR and BN strains is presented. The PD/Cub strain has been bred by brother sister mating for more than 60 generations since 1969. Its highly inbred status has been confirmed by PCR genotyping with more than 170 microsatellite markers. No case of residual heterozygosity has been recorded. Accordingly, the values obtained by the analysis of metabolic phenotypes are homogeneous with low variance. The PD/Cub strain has significantly higher triglyceride levels and epididymal fat weight as compared to both SHR and BN strains. The PD strain also displays the lowest incorporation of 14C-U glucose into the epididymal adipose tissue. The data on glucose metabolism clearly indicate that the PD/Cub strain is insulin resistant. Genetic homogeneity and reproducibility of experimental results qualify the PD/Cub rats as an animal model for analysis of the syndrome X.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10925780

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  10 in total

1.  Rat Models of Metabolic Syndrome.

Authors:  Anne E Kwitek
Journal:  Methods Mol Biol       Date:  2019

2.  CD36-deficient congenic strains show improved glucose tolerance and distinct shifts in metabolic and transcriptomic profiles.

Authors:  L Šedová; F Liška; D Křenová; L Kazdová; J Tremblay; M Krupková; G Corbeil; P Hamet; V Křen; O Šeda
Journal:  Heredity (Edinb)       Date:  2012-04-04       Impact factor: 3.821

3.  Metabolic effects of telmisartan in spontaneously hypertensive rats.

Authors:  Yong-Qi Li; Hui Ji; Yi-Hua Zhang; Da-Yong Ding; Xiao-Lei Ye
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-05-20       Impact factor: 3.000

Review 4.  Parental overnutrition by carbohydrates in developmental origins of metabolic syndrome.

Authors:  O Šeda
Journal:  Physiol Res       Date:  2021-12-30       Impact factor: 2.139

5.  Hepatic Transcriptome Profiling Reveals Lack of Acsm3 Expression in Polydactylous Rats with High-Fat Diet-Induced Hypertriglyceridemia and Visceral Fat Accumulation.

Authors:  Kristýna Junková; Lukáš F Mirchi; Blanka Chylíková; Michaela Janků; Jan Šilhavý; Martina Hüttl; Irena Marková; Denisa Miklánková; Josef Včelák; Hana Malínská; Michal Pravenec; Ondřej Šeda; František Liška
Journal:  Nutrients       Date:  2021-04-25       Impact factor: 5.717

6.  Genomic determinants of triglyceride and cholesterol distribution into lipoprotein fractions in the rat.

Authors:  Miloslava Hodúlová; Lucie Šedová; Drahomíra Křenová; František Liška; Michaela Krupková; Ludmila Kazdová; Johanne Tremblay; Pavel Hamet; Vladimír Křen; Ondřej Šeda
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

7.  Single-Gene Congenic Strain Reveals the Effect of Zbtb16 on Dexamethasone-Induced Insulin Resistance.

Authors:  Michaela Krupková; František Liška; Ludmila Kazdová; Lucie Šedová; Adéla Kábelová; Drahomíra Křenová; Vladimír Křen; Ondřej Šeda
Journal:  Front Endocrinol (Lausanne)       Date:  2018-04-20       Impact factor: 5.555

8.  Quercetin supplementation alters adipose tissue and hepatic transcriptomes and ameliorates adiposity, dyslipidemia, and glucose intolerance in adult male rats.

Authors:  Adéla Kábelová; Hana Malínská; Irena Marková; Martina Hűttl; Blanka Chylíková; Ondřej Šeda
Journal:  Front Nutr       Date:  2022-09-29

9.  SHR-Zbtb16 minimal congenic strain reveals nutrigenetic interaction between Zbtb16 and high-sucrose diet.

Authors:  E Školníková; L Šedová; F Liška; O Šeda
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

10.  Grandmother's Diet Matters: Early Life Programming with Sucrose Influences Metabolic and Lipid Parameters in Second Generation of Rats.

Authors:  Elena Školníková; Lucie Šedová; Ondřej Šeda
Journal:  Nutrients       Date:  2020-03-21       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.